`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________________________________________
`
`
`HOPEWELL PHARMA VENTURES, INC.,
`Petitioner,
`
`v.
`
`MERCK SERONO SA,
`Patent Owner.
`
`____________________________________________
`
`Case IPR2023-00481
`U.S. Patent No. 8,377,903
`____________________________________________
`
`PATENT OWNER’S
`MANDATORY NOTICES UNDER 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`Patent Owner’s Mandatory Notices
`IPR2023-00481
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner respectfully submits this
`
`
`
`Mandatory Notice within 21 days of service of the Petition (Paper 2).
`
`I.
`
`37 C.F.R. § 42.8(b)(1) – Real Party-in-Interest
`
`The Real Parties-in-Interest for the Patent Owner are Merck Serono SA,
`
`Merck KGaA, and Ares Trading SA. Merck Serono SA and Ares Trading SA are
`
`wholly owned subsidiaries of Merck KGaA.
`
`II.
`
`37 C.F.R. § 42.8(b)(2) – Related Matters
`
`U.S. Patent No. 8,377,903 (“the ’903 patent”) is a patent-in-suit in the
`
`following litigations: Merck KGaA, Merck Serono SA, and Ares Trading SA v.
`
`Accord Healthcare, Inc., No. 1:22-cv-00974-GBW (D. Del.), Merck KGaA, Merck
`
`Serono SA, and Ares Trading SA v. Hopewell Pharma Ventures, Inc., No. 1:22-cv-
`
`01365-GBW (D. Del.), and Merck KGaA, Merck Serono SA, and Ares Trading SA
`
`v. Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited, No. 1:23-cv-
`
`00039-GBW (D. Del.).
`
`The ’903 patent is related to U.S. Patent No. 7,713,947 (“the ’947 patent”),
`
`where the ’903 patent issued from an application that was filed as a continuation of
`
`the ’947 patent. Petitioner has concurrently filed a petition for inter partes review
`
`of the ’947 patent, which was filed as IPR2023-00480. Additionally, the ’903
`
`patent and the ’947 patent are subject to the following inter partes review petitions:
`
`
`
`1
`
`
`
`TWi Pharmaceuticals, Inc. v. Merck Serono SA, IPR2023-00050 and TWi
`
`Patent Owner’s Mandatory Notices
`IPR2023-00481
`
`
`Pharmaceuticals, Inc. v. Merck Serono SA, IPR2023-00049, respectively.
`
`III. Lead And Back-Up Counsel Under § 42.8(b)(3)
`
`Pursuant to 37 C.F.R. § 42.8(b)(3), Patent Owner designates the following
`
`Lead and Back-up Counsel. A power of attorney is concurrently submitted
`
`herewith pursuant to 37 C.F.R. § 42.10(b).
`
`Lead Counsel
`Emily R. Whelan
`Reg. No. 50,391
`Wilmer Cutler Pickering Hale and Dorr
`LLP
`60 State Street
`Boston, MA 02109
`Tel: 617-526-6567
`Email: Emily.Whelan@wilmerhale.com
`
`Back-up Counsel
`Deric Geng
`Reg. No. 73,434
`Wilmer Cutler Pickering Hale and Dorr
`LLP
`60 State Street
`Boston, MA 02109
`Tel: 617-526-6026
`Email: Deric.Geng@wilmerhale.com
`
`Cindy Kan
`Reg. No. 76,385
`Wilmer Cutler Pickering Hale and Dorr
`LLP
`7 World Trade Center
`250 Greenwich Street
`New York, NY 10007
`Tel: 212-295-6470
`Email: Cindy.Kan@wilmerhale.com
`IV. 37 C.F.R. § 42.8(b)(4) – Service Information
`
`Patent Owner consents to electronic email service at:
`
`Emily.Whelan@wilmerhale.com
`Deric.Geng@wilmerhale.com
`
`
`
`2
`
`
`
`Patent Owner’s Mandatory Notices
`IPR2023-00481
`
`
`Cindy.Kan@wilmerhale.com
`WHMerckMavencladIPRs@wilmerhale.com
`
`Post and hand delivery correspondence and service may be sent to:
`
`Emily R. Whelan
`Wilmer Cutler Pickering Hale and Dorr LLP
`60 State Street
`Boston, MA 02109
`Tel: 617-526-6567; Facsimile: (617) 526-5000
`
`Date: February 10, 2023
`
`
`
`
`
`
`Respectfully submitted,
`
`By: /Emily R. Whelan/
`Emily R. Whelan (Reg. No. 50,391)
`Wilmer Cutler Pickering Hale and Dorr LLP
`60 State Street
`Boston, MA 02109
`Tel: (617) 526-6567
`Email: Emily.Whelan@wilmerhale.com
`
`3
`
`
`
`Patent Owner’s Mandatory Notices
`IPR2023-00481
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on February 10, 2023, a true and correct copy of the
`
`following documents:
`
` Patent Owner’s Mandatory Notices Under 37 C.F.R. § 42.8
`
` Merck Serono SA Power of Attorney Under 37 C.F.R. §42.10
`
`were served via e-mail on the following attorneys of record:
`
`eellison-PTAB@sternekessler.com
`opartington-PTAB@sternekessler.com
`cvira-PTAB@sternekessler.com
`jcrozendaal-PTAB@sternekessler.com
`PTAB@sternekessler.com
`
`
`
`
`By: /Cindy Kan/
`
`Cindy Kan (Reg. No. 76,385)
`Wilmer Cutler Pickering Hale and Dorr LLP
`7 World Trade Center
`250 Greenwich Street
`New York, NY 10007
`Tel: 212-295-6470
`Email: Cindy.Kan@wilmerhale.com
`
`
`
`4
`
`